(4S)-2,2-DIOXIDO-4-METHYL-1,2,3-OXATHIAZOLIDINE, N-BOC PROTECTED, 95.0%, 5g

2,1,3-Benzothiadiazole>99.0%(GC)25g

1,2-Butylene Oxide>99.0%(GC)500mL

K-Oxima, PEPTIPURE®, mínimo 99 %, 50 g, envase de vidrio

2-(4-Fluorophenoxy)acetohydrazide, 98.0%, 1g

3,4-dimethyl-4'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone, 97.0%, 1g

Cyclopent-1-ene-1,2-dicarboxylic acid, 95+%, 100mg

2-OXO-1,2-DIHYDRO-[1,8]NAPHTHYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER, 95.0%, 250mg

3-((Difluoromethyl)thio)benzoic acid, 98%, 500mg

(R)-2-Benzyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole, 97%, 1g

1-Ethyl-3-methyl-1h-pyrazole, 95+%, 5g

1-Bromo-5-chloro-2-fluoro-4-isopropoxybenzene, 95%, 500mg

1-Nitro-4-(2,2,2-trifluoroethoxy)benzene, 25g